Cancer drug fails trial

aN aStRaZENECa cancer drug failed to meet targets in a study of whether it could be used on patients with advanced head and neck cancer.

immunotherapy treatment imfinzi did not improve survival rates compared to standard chemotherapy.

imfinzi is already approved for treating lung cancer and advanced bladder cancer, but astra is trying to see if it can be used on other variations of the disease.